Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model

Turgut B., Gul F. C., Dagli F., Ilhan N., Ozgen M.

DRUG DESIGN DEVELOPMENT AND THERAPY, vol.7, pp.19-24, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2013
  • Doi Number: 10.2147/dddt.s39453
  • Journal Name: DRUG DESIGN DEVELOPMENT AND THERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.19-24
  • Keywords: uveitis, tumor necrosis factor-alpha, interleukin-1, interleukin-6, infliximab, ghrelin, TUMOR-NECROSIS-FACTOR, THREATENING PANUVEITIS, ORGAN INJURY, INFLIXIMAB, EYE, INTERLEUKIN-6, INFLAMMATION, PEPTIDE
  • Çanakkale Onsekiz Mart University Affiliated: No

Abstract

Background: The purpose of this study was to investigate the effect of intraperitoneal ghrelin on vitreous levels of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNF-alpha) and to compare its effects with those of intraperitoneal infliximab in an experimental uveitis model.